Skip to content

Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy électrochimique cutanée

Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03506659
Enrollment
4000
Registered
2018-04-24
Start date
2018-03-01
Completion date
2020-01-30
Last updated
2020-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difference, Individual

Brief summary

Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers

Detailed description

Objective: Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers Background: Sudoscan is a tool developed to evaluate and screen peripheral neuropathies in diabetes. His indication has been extended to other neuropathies such as post-chemotherapy, Fabry's disease, Parkinson's disease, familial amyloid polyneuropathy. Main objective: Evaluation of the relevance of cutaneous electrochemical conductance in chronic peripheral neuropathies. Methodology : Recruitment of 2 groups of 2000 patients Group 1: Patients with chronic neuropathy, during clinic bread consultation Group 2: Patients to benefit from scheduled surgery seen during anesthesia consultation For both groups filling the central awareness inventory questionnaire Analysis of the results after the recruitment has been completed.

Interventions

DEVICESUDO-SCAN Device

Sudo-scan is a machine with 2 palets for hands and 2 palets for foots. The patient has to put his 2 hands and 2 foots on the machine. The machine do the measures during 2 minutes.

Sponsors

Erasme University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Parallel group open label Monocentric

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult

Exclusion criteria

* Patients group : Not have a chronic neuropathy

Design outcomes

Primary

MeasureTime frameDescription
Difference of timing for Electrochemical skin conductance3 minutesthe investigators will measure the timing between the 4 members for the Electrochemical skin conductance

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026